OnKure Therapeutics (OKUR) Earnings Date & Reports

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

OKUR is expected to report earnings to fall 54.05% to -50 cents per share on November 05

OnKure Therapeutics OKUR Stock Earnings Reports

Q3'26

Est.

$-0.51

Q1'26

Missed

by $0.05

Q4'25

Missed

by $0.80

Q3'25

Missed

by $0.78

Q2'25

Missed

by $0.64

The last earnings report on May 05 showed earnings per share of -111 cents, missing the estimate of -105 cents. With 162.08K shares outstanding, the current market capitalization sits at 127.05M.

View a ticker or compare two or three

OKUR

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for OKUR